UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 12, 2009
--------------
PFIZER INC.
-----------
(Exact name of registrant as specified in its charter)
Delaware 1-3619 13-5315170
-------- ------ ----------
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification
incorporation) Number)
235 East 42nd Street, New York, New York 10017
----------------------------------------------------------
(Address of principal executive offices) (zip code)
Registrant's telephone number, including area code: (212) 573-2323
--------------
Not Applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|X| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
Pfizer Inc., a Delaware corporation (the "Company"), Wagner Acquisition
Corp., a Delaware corporation and direct wholly-owned subsidiary of the
Company, and Wyeth, a Delaware corporation, entered into a definitive
Agreement and Plan of Merger dated as of January 25, 2009 (the "Merger").
Also on January 25, 2009, the Company entered into a bridge term facility
commitment letter pursuant to which a syndicate of lenders comprised of
JPMorgan Chase Bank, N.A. ("JP Morgan Chase"), Bank of America, N.A.,
Barclays Bank PLC, Citigroup Global Markets Inc. and Goldman Sachs Credit
Partners L.P. committed to provide $22.5 billion to finance a portion of the
consideration to be paid in the Merger.
On March 12, 2009, the bridge term facility was syndicated to twenty-nine
additional lenders in addition to the five initial bridge lenders. The maximum
exposure for any single lender under the bridge term facility will not exceed
$1.5 billion. Also on March 12, 2009, the Company entered into a 364-day bridge
loan credit agreement, under which JPMorgan Chase is the administrative agent,
J.P. Morgan Securities Inc., Banc of America Securities LLC, Barclays Capital,
Citigroup Global Markets Inc., and Goldman Sachs Credit Partners L.P. are joint
lead arrangers, and Banc of America Securities LLC, Barclays Capital, Citibank,
N.A., and Goldman Sachs Capital Partners L.P. are joint syndication agents.
The bridge term facility provides the Company with unsecured financing in
an aggregate principal amount of up to $22.5 billion. The term of a portion of
the bridge term facility may be extended, at the option of the Company, for up
to 180 days following expiration of its initial term, subject to certain
conditions, including payment by the Company of certain applicable fees to the
lenders. Amounts outstanding under the bridge term facility will bear interest,
at the Company's option, either (a) at the base rate (defined as the highest of
(1) JPMorgan Chase's prime rate, (2) the federal funds rate plus 0.50% and (3)
the adjusted LIBO rate for a one month interest period beginning on such day
plus 1.00%) or (b) at the reserve adjusted eurodollar rate plus, in each case,
an applicable margin.
The Company may voluntarily prepay the loans at anytime without premium or
penalty. The bridge term facility requires mandatory prepayments with the net
cash proceeds of certain liquidating events. The bridge loan agreement also
contains certain events of default, upon the occurrence of which, and so long as
such event of default is continuing, the amounts outstanding will accrue
interest at an increased rate and payments of such outstanding amounts could be
accelerated by the lenders. In addition, the Company will be subject to certain
affirmative and negative covenants under the bridge loan agreement.
The lenders or their affiliates have in the past engaged, and may in the
future engage, in transactions with and perform services, including commercial
banking, financial advisory and investment banking services, for the Company and
its affiliates in the ordinary course of business for which they have received
or will receive customary fees and expenses. In addition, affiliates of certain
of the lenders are providing advisory services to the Company in connection with
the Merger.
The description of the bridge loan agreement above is a summary and is
qualified in its entirety by reference to the bridge loan agreement, a copy of
which is attached as Exhibit 10.1 to this report and incorporated herein by
reference.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant
The information set forth in Item 1.01 above is hereby incorporated by
reference under this Item 2.03.
Additional Information
In connection with the proposed Merger, the Company will file with the SEC a
Registration Statement on Form S-4 that will include a proxy statement of Wyeth
that also constitutes a prospectus of the Company. Wyeth will mail the proxy
statement/prospectus to its stockholders. The Company and Wyeth urge investors
and security holders to read the proxy statement/prospectus regarding the
proposed Merger when it becomes available because it will contain important
information. You may obtain copies of all documents filed with the SEC regarding
this transaction, free of charge, at the SEC's website (www.sec.gov). You may
also obtain these documents, free of charge, from the Company's website,
www.pfizer.com, under the tab "Investors" and then under the tab "SEC Filings".
You may also obtain these documents, free of charge, from Wyeth's website,
www.wyeth.com, under the heading "Investor Relations" and then under the tab
"Financial Reports/SEC Filings".
The Company, Wyeth and their respective directors, executive officers and
certain other members of management and employees may be soliciting proxies from
Wyeth stockholders in favor of the Merger. Information regarding the persons who
may, under the rules of the SEC, be deemed participants in the solicitation of
the Wyeth stockholders in connection with the proposed Merger will be set forth
in the proxy statement/prospectus when it is filed with the SEC. You can find
information about the Company's executive officers and directors in its
definitive proxy statement filed with the SEC on March 14, 2008. You can find
information about Wyeth's executive officers and directors in its definitive
proxy statement filed with the SEC on March 14, 2008. You can obtain free copies
of these documents from the Company and Wyeth using the contact information
above.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
- ----------- -----------
10.1 364-Day Bridge Term Loan Credit Agreement, with the lenders
party thereto, JPMorgan Chase Bank, N.A., as administrative
agent, J.P. Morgan Securities Inc., Banc of America Securities
LLC, Barclays Capital, Citigroup Global Markets Inc., and
Goldman Sachs Credit Partners L.P., as joint lead arrangers,
and Banc of America Securities LLC, Barclays Capital,
Citibank, N.A., and Goldman Sachs Capital Partners L.P., as
joint syndication agents
SIGNATURES
Under the requirements of the Securities Exchange Act of 1934, the registrant
has caused this report to be signed on its behalf by the authorized undersigned.
PFIZER INC.
By: /s/ Matthew Lepore
------------------------------------------------
Name: Matthew Lepore
Title: Vice President, Chief Counsel-Corporate
Governance, and Assistant General Counsel
Dated: March 12, 2009
PFIZER INC.
FORM 8-K
CURRENT REPORT
EXHIBIT INDEX
-------------
Exhibit No. Description
- ----------- -----------
10.1 364-Day Bridge Term Loan Credit Agreement, with the lenders
party thereto, JPMorgan Chase Bank, N.A., as administrative
agent, J.P. Morgan Securities Inc., Banc of America Securities
LLC, Barclays Capital, Citigroup Global Markets Inc., and
Goldman Sachs Credit Partners L.P., as joint lead arrangers,
and Banc of America Securities LLC, Barclays Capital,
Citibank, N.A., and Goldman Sachs Capital Partners L.P., as
joint syndication agents